Erica Lamberg
- Indexed articles, last 90 days
- 14
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Navigating GLP-1 Switches: A Guide for Primary Care (opens the original)
Read excerpt
As GLP-1 receptor agonists and dual incretin agents become more common in treating obesity and type 2 diabetes, primary care providers are handling more medication switches. The reason may be insurance coverage, ongoing gastrointestinal side effects, inadequate response, or the need for better blood sugar control or weight support. Whatever the driver, switching is not simply trading one prescription for another. It requires planning around half-lives, dose history, side effects, and the risk fo
What Thriving Hospitalists Know About Building Careers (opens the original)
Read excerpt
Hospitalists practice at the center of acute inpatient care, managing complex clinical situations, coordinating with subspecialists, navigating discharge planning, and responding to the operational pressures that shape hospital throughput and patient safety. The work can be demanding, with long shifts, high case levels, administrative burdens, and burnout risk. Yet doctors in hospital medicine point to the specialty’s flexibility, varied practice models, leadership paths and broad clinical scope
How to Help Manage Depression After GLP-1 Weight Regain (opens the original)
Read excerpt
With more patients using GLP-1 weight-loss medications, physicians are increasingly seeing patients who discontinued therapy because of cost, limited pharmacy availability, intolerable adverse effects, or loss of insurance coverage. After patients discontinue medication, weight regain is common, and that may affect their mental health, confidence, and willingness to return for follow-up care. Because the duration of GLP-1 therapy is often uncertain, physicians should begin discussions early so p
There Are Options for Patients at the Highest GLP-1 Dose (opens the original)
Read excerpt
Even after careful GLP-1 dose titration, significant weight loss and marked improvement on other health markers, some patients will reach the maximum dose. This milestone is an opportunity to review clinical strategies, reinforce behavior changes, and to lead patients toward continued progress. After weight loss, patients should not “coast,” said Amy Sheer, MD, MPH, an internal medicine and obesity medicine physician at UF Health Internal Medicine in Gainesville, Florida. “They should continue p
Sleep and Obesity Are Intertwined. Do Naps Help or Hurt? (opens the original)
Read excerpt
During discussion with patients, they may share their struggles with both getting enough sleep and staying asleep. Some may say they rely on naps to maintain alertness throughout the day. And the link between sleep and weight is undeniable. Lack of sleep often triggers strong cravings, especially for high‑fat, high‑sugar snacks, Fariha Abbasi-Feinberg explained. “It ramps up brain reward systems and endocannabinoids, making junk food even more appealing while weakening self-control,” said Abbasi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.